NorthWest Biotherapeutics Inc (NWBO)

[Sojourner55]

So Sushifishman has a $1.00 target by end of June which I concur. That's the next major high since Oct 2016. That's also the post diluted high equivalent to $12 plus taking into account a roughly 12 times dilution from 100M to 1.2B shares. We once achieved close to $1B market cap in anticipation of results before the trial was re-sized so I do think we will get close to that number pre-TLD, in other words, $1.

Only time will tell and it won't be long.